Repurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection

There are currently no FDA-approved therapeutics available to treat Rift Valley fever virus (RVFV) infection. In an effort to repurpose drugs for RVFV treatment, a library of FDA-approved drugs was screened to determine their ability to inhibit RVFV. Several drugs from varying compound classes, incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Benedict, Ashwini, Bansal, Neha, Senina, Svetlana, Hooper, Idris, Lundberg, Lindsay, de la Fuente, Cynthia, Narayanan, Aarthi, Gutting, Bradford, Kehn-Hall, Kylene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495339/
https://www.ncbi.nlm.nih.gov/pubmed/26217313
http://dx.doi.org/10.3389/fmicb.2015.00676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495339/
https://www.ncbi.nlm.nih.gov/pubmed/26217313
http://dx.doi.org/10.3389/fmicb.2015.00676

Ejemplares similares